参考文献/References:
[1] Brent GA. Clinical practice. Graves' disease[J].N Engl J Med,2008,358(24):2594-2605. DOI: 10.1056/NEJMcp0801880.
[2] Dobyns BM, Sheline GE, Workman JB,et al. Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the cooperative thyrotoxicosis therapy follow-up study[J].J Clin Endocrinol Metab,1974,38(6):976-998.
[3] Mishra A, Mishra SK. Thyroid nodules in Graves' disease: implications in an endemically iodine deficient area[J].J Postgrad Med,2001,47(4):244-247.
[4] Gerenova J, Buysschaert M, de Burbure CY, et al. Prevalence of thyroid cancer in Graves' disease: a retrospective study of a cohort of 103 patients treated surgically[J].Eur J Intern Med,2003,14(5):321-325.
[5] Marine D, Lenhart CH. Pathological anatomy of exophalmic goiter--the anatomical and physiological relations of the thyroid gland to the disease; the treatment[J]. Arch Intern Med, 1911,8(3):265-316.
[6] Marine D. Benign epithelial tumors of the thyroid gland[J]. J Med Res, 1913,27(3):229-268.
[7] Charkes ND. Graves' disease with functioning nodules(Marine-Lenhart syndrome)[J].J Nucl Med,1972,13(12):885-892.
[8] El-Kaissi S, Kotowicz MA, Goodear M,et al. An unusual case of Marine-Lenhart syndrome[J].Thyroid,2003,13(10):993-994.
[9] Cakir M. Marine-Lenhart syndrome[J].J Natl Med Assoc, 2005,97(7):1036-1038.
[10] Giuffrida G, Giovinazzo S, Certo R,et al. An uncommon case of Marine-Lenhart syndrome[J].Arq Bras Endocrinol Metabol,2014,58(4):398-401.
[11] 牛娜, 林岩松, 陈永辉, 等. Marine-Lenhart综合征一例[J]. 中华内分泌代谢杂志, 2010,26(6):521-522. DOI:10.3760/cma.j.issn.1000-6699.2010.06.027.
[12] Chandramouly B, Mann D, Cunningham RP,et al. Marine-Lenhart syndrome. Graves' disease with poorly functioning nodules[J].Clin Nucl Med,1992,17(11):905-906.
[13] Brahma A, Beadsmoore C, Dhatariya K. The oldest case of Marine-Lenhart syndrome[J].JRSM Short Rep,2012,3(4):21. DOI: 10.1258/shorts.2011.011164.
[14] Carnell NE, Valente WA. Thyroid nodules in Graves' disease: classification, characterization, and response to treatment[J].Thyroid,1998,8(8):647-652.
[15] Poertl S, Kirner J, Saller B,et al. T3-release from autonomously functioning thyroid nodules in vitro[J].Exp Clin Endocrinol Diabetes,1998,106(6):489-493.
[16] Biersack HJ, Biermann K. The Marine-Lenhart syndrome revisited[J].Wien Klin Wochenschr, 2011,123(15-16):459-462. DOI: 10.1007/s00508-011-0029-5.
[17] Bahn Chair RS, Burch HB, Cooper DS,et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists[J].Thyroid,2011,21(6):593-646. DOI: 10.1089/thy.2010.0417.
[18] Braga-Basaria M, Basaria S. Marine-Lenhart syndrome[J].Thyroid,2003,13(10):991.
[19] Takei M, Ishii H, Sato Y, et al. A case of Marine-Lenhart syndrome with a negative TSH receptor antibody titer successfully treated with a fixed, low dose of 131I[J]. Case Rep Endocrinol, 2014,2014:1-4.DOI:10.1155/2014/423563.